4th Swiss Industrial Chemistry Symposium
27. January 2023
University of Basel, Department of Chemistry
University of Basel, Department of Chemistry
Program
08.30
Welcome coffee
Visit exhibitors and chat about the latest developemnts on the market.
Pinning posters to the pannes for the poster session.
Visit exhibitors and chat about the latest developemnts on the market.
Pinning posters to the pannes for the poster session.
09.00
Opening of the Symposium
Welcome Messages by Dr. Olivier Baudoin, University of Basel and Dr. Thomas Heinz, Novartis AG
Welcome Messages by Dr. Olivier Baudoin, University of Basel and Dr. Thomas Heinz, Novartis AG
Session 1
Chair: Dr. Hayley Binch, Roche
09.15
Helmars Smits and Paul Burton, Syngenta Crop Protection AG
«Process Research and Development of a Novel Herbicide Candidate»
«Process Research and Development of a Novel Herbicide Candidate»
09.45
Valerie Runtz-Schmitt, F. Hoffmann-La Roche AG
«New Therapeutic Opportunities for Subtype Selective GABA-A Modulators»
«New Therapeutic Opportunities for Subtype Selective GABA-A Modulators»
10.15
Coffee Break
Session 2
Chair: Dr. René Wyler, Novartis
10.45
Florent Heroguel, Bloom
«A journey Towards Fossil-free World Using Controlled Chemical Biomass Transformation»
«A journey Towards Fossil-free World Using Controlled Chemical Biomass Transformation»
11.00
Cara Brocklehurst, Novartis Pharma AG
«MicroCycle: a Machine Learning Driven, Automated and Integrated Platform for Drug Discovery»
«MicroCycle: a Machine Learning Driven, Automated and Integrated Platform for Drug Discovery»
11.15
Jean-Francois Basset, Firmenich SA
«From Pine to Perfume»
«From Pine to Perfume»
11.45
Achim Link, Solvias AG
«Earth-Abundant Transition Metals in Catalysis»
«Earth-Abundant Transition Metals in Catalysis»
12.00
Benedikt Wanner, Synple
«Accelerating Discovery with Automated Capsule Chemistry»
«Accelerating Discovery with Automated Capsule Chemistry»
12.15
Lunch Break, Networking
Poster Session
Commercial Exhibition: latest developments on the market from our partners
Poster Session
Commercial Exhibition: latest developments on the market from our partners
Session 3
Chair: Dr. Sarah Sulzer, Syngenta
14.00
Rüdiger Haug, Bachem AG
«Innovative Oligonucleotide Production at Bachem»
«Innovative Oligonucleotide Production at Bachem»
14.30
Simon Wagschal, Cilag AG (Johnson & Johnson)
«Chemical Development of Adafosbuvir»
«Chemical Development of Adafosbuvir»
15.00
Bernhard Fasching, Monte Rosa Therapeutics
«From Serendipity to Rational Design; Taking Molecular Glue Degraders to New Heights»
«From Serendipity to Rational Design; Taking Molecular Glue Degraders to New Heights»
15.15
Coffee Break
Session 4
Chair: Dr. Stefan Hildbrand, Roche
15.45
Gabriel Schäfer, Idorsia Pharmaceuticals Ltd.
«Development of a Stereoselective Route for CXCR7 Antagonist ACT-1004-1239»
«Development of a Stereoselective Route for CXCR7 Antagonist ACT-1004-1239»
16.15
Lucie Lovelle and Robert Pulz, Novartis Pharma AG
«Discovery and Development of Remibrutinib»
«Discovery and Development of Remibrutinib»
16.45
Ceremony of the Prize for the Best Posters and 3x 2min elevator talks by the winners.
Closing remarks and outlook by Dr. Fabrice Gallou, Novartis and Prof. Christian Bochet, President of the SCS
Closing remarks and outlook by Dr. Fabrice Gallou, Novartis and Prof. Christian Bochet, President of the SCS
17.00
End of the lecture sessions.
Aperitif and networking.
Aperitif and networking.